Asia Pacific Prescription Digital Therapeutics Dtx Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2022 –2029 |
 Taille du marché (année de référence) |
USD 96.38 Billion |
 Taille du marché (année de prévision) |
USD 545.70 Billion |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique , par mécanisme (mécanismes d'entrée, mécanismes de sortie), catégorie ( augmentation de la médication , remplacement de médicament), traitement (traitement ambulatoire, monothérapie), logiciel (logiciel pour les affections respiratoires, logiciel pour la santé mentale , logiciel pour les troubles liés à l'utilisation d'opioïdes, logiciel pour le diabète, autres), services (microservices comportementaux, microservices médicaux), accessibilité des applications (Android, iOS, Windows), type d'application (applications natives, applications Web), application (trouble lié à l'utilisation de substances (SUD), trouble lié à l'utilisation d'opioïdes (OUD), trouble déficitaire de l'attention/hyperactivité (TDAH), maladie d'Alzheimer, trouble dépressif majeur (TDM), insomnie, épilepsie, trouble du mouvement, sclérose en plaques, migraine, trouble du spectre autistique, oncologie, inflammation, respiratoire, cardiovasculaire, gestion de la douleur, troubles métaboliques, autres), patients (enfants, adultes) - Tendances de l'industrie et prévisions jusqu'en 2029
Analyse et taille du marché
Les thérapies numériques sur ordonnance sont une stratégie unique qui permet aux implémentations logicielles de traiter rapidement les principales maladies. Elle est conçue pour fournir un traitement fondé sur des preuves partout et à tout moment et fournir aux médecins des données en temps réel sur l'évolution des patients. Des thérapies numériques sur ordonnance ont été développées et sont en cours de développement pour une variété de maladies, notamment les troubles liés à l'utilisation de substances (SUD), les troubles liés à l'utilisation d'opioïdes (OUD), le TDAH, le trouble dépressif majeur (MDD), l'insomnie , la sclérose en plaques, l'oncologie, la migraine , l'épilepsie, les troubles du spectre autistique et les maladies cardiovasculaires. Les patients ayant diverses exigences non satisfaites peuvent trouver que les thérapies numériques sur ordonnance sont l'aspect le plus crucial de leur vie.
Français Data Bridge Market Research analyse que le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique était évalué à 96,38 millions USD en 2021 et devrait atteindre 545,70 millions USD d'ici 2029, enregistrant un TCAC de 24,2 % au cours de la période de prévision de 2022 à 2029. En plus des informations sur le marché telles que la valeur du marché, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de recherche sur le marché Data Bridge comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.
Portée du rapport et segmentation du marché
|
Rapport métrique |
Détails |
|
Période de prévision |
2022 à 2029 |
|
Année de base |
2021 |
|
Années historiques |
2020 (personnalisable de 2014 à 2019) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
|
Segments couverts |
Mechanism (Input Mechanisms, Output Mechanisms), Category (Medication Augmentation, Medication Replacement), Treatment (Outpatient Treatment, Monotherapy), Software (Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes, Others), Services (Behavioral Microservices, Medical Microservices), App Accessibility (Android, iOS, Windows), App Type (Native Apps, Web Apps), Application (Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others), Patients (Children, Adults), |
|
Countries Covered |
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC) |
|
Market Players Covered |
ResMed (US), SAMSUNGHEALTHCARE (South Korea), Biofourmis (US), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (US), Voluntis (France) |
|
Market Opportunities |
|
Market Definition
Prescription digital therapies is a type of software that is used to treat a variety of ailments. Prescription digital medicines were created by combining biology and technology. Artificial intelligence, diverse algorithms, and virtual reality are used to create these therapeutic instruments. Patients might use prescription digital therapeutics software and services to get any form of treatment whenever and wherever they needed it. Prescription digital treatments have gained a lot of popularity since they are tightly regulated by the FDA and other regulatory authorities and can only be used with a proper prescription from a doctor.
Asia-Pacific Prescription Digital Therapeutics (PDTx) Market Dynamics
Drivers
- Rise in the prevalence of chronic diseases
The surging prevalence of chronic diseases is a major factor driving the prescription digital therapeutics (PDTx) market's growth rate during the forecast period of 2022-2029. As per the World Health Organization (WHO), 463 million adults would have diabetes in 2020. According to predictions, there would be roughly 629 million diabetics worldwide by 2045.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of prescription digital therapeutics (PDTx) market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Furthermore, rising adoption rate of smartphones and tablets will expand the prescription digital therapeutics (PDTx) market. Additionally, increasing government initiatives for better healthcare services and surging geriatric population will result in the expansion of prescription digital therapeutics (PDTx) market. Along with this, easy accessibility, patient comfort, and the potentiality to influence behavioural change will enhance the market's growth rate.
Opportunities
- Strong pipeline of potential products
A significant pipeline of potential items projected to be released throughout the forecast period will provide beneficial opportunities for the prescription digital therapeutics (PDTx) market growth. Pear-011 (anxiety GAD), Pear-015 (depression MDD), which are used in the treatment of adults with chronic insomnia and depression, and CT-152 (major depressive disorder), CT-155 (schizophrenia), which are used in the treatment of adults with schizophrenia and depression, are illustrations of potential pear therapeutics clinical therapeutics products in phase III. As a result, various late-stage drugs in the pipeline are anticipated to give attractive prospects for the digital therapeutics market to flourish.
The market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the biologics market growth. Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of prescription digital therapeutics (PDTx) during the forecast period.
Restraints/Challenges
On the other hand, patient data privacy concerns will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the prescription digital therapeutics (PDTx) market. Additionally, strict government regulations and lack of awareness about digital therapeutics in developing countries will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.
This Asia-Pacific prescription digital therapeutics (PDTx) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Asia-Pacific prescription digital therapeutics (PDTx) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Analyse épidémiologique des patients
Le marché des thérapies numériques sur ordonnance (PDTx) vous fournit également une analyse de marché détaillée pour l'analyse des patients, le pronostic et les remèdes. La prévalence, l'incidence, la mortalité et les taux d'adhésion sont quelques-unes des variables de données disponibles dans le rapport. Les analyses d'impact directes ou indirectes de l'épidémiologie sur la croissance du marché sont analysées pour créer un modèle statistique multivarié de cohorte plus robuste pour prévoir le marché pendant la période de croissance.
Impact du COVID-19 sur le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique
La COVID-19 a une influence générale positive sur le secteur des thérapies numériques sur ordonnance (PDTx). En raison de la prise de conscience mondiale accrue de l’importance de la santé numérique, de la prévalence des maladies mentales et du taux de consommation de médicaments. En outre, comme les individus ont été contraints de rester chez eux pendant la pandémie, moins d’exercice physique, un mode de vie malsain et le stress mental ont augmenté la prévalence des maladies chroniques. En conséquence, la demande d’appareils et de logiciels de thérapies numériques sur ordonnance (PDTx) augmente dans le monde entier. Le secteur devrait encore croître puisque les autorisations réglementaires pour les traitements basés sur les thérapies numériques sur ordonnance (PDTx) ont récemment été assouplies.
En pleine épidémie de COVID-19, la FDA américaine a émis des avis provisoires concernant les médicaments de santé mentale de Pear Therapeutics. Cela implique également que les organismes de réglementation reconnaissent l'importance des produits thérapeutiques numériques. En outre, les entreprises de santé numérique aux États-Unis ont levé 5,4 milliards de dollars de capital-risque au premier semestre 2020, un record dans l'histoire du financement de la santé numérique, ce qui indique que les investisseurs estiment que ces solutions sont nécessaires. Par conséquent, la pandémie de COVID-19 devrait stimuler le marché des thérapies numériques sur ordonnance (PDTx).
Portée du marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique
Le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique est segmenté en fonction du mécanisme, de la catégorie, du traitement, des logiciels, des services, de l'accessibilité des applications, du type d'application, de l'application et des patients. La croissance de ces segments vous aidera à analyser les faibles segments de croissance des industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Mécanisme
- Mécanismes d'entrée
- Mécanismes de sortie
Catégorie
- Augmentation de la médication
- Remplacement de médicaments
Traitement
- Traitement ambulatoire
- Monothérapie
Logiciel
- Logiciel pour les maladies respiratoires
- Logiciel pour la santé mentale
- Logiciel pour les troubles liés à l'usage d'opioïdes
- Logiciel pour le diabète
- Autres
Services
- Microservices comportementaux
- Microservices médicaux
Accessibilité des applications
- Androïde
- iOS
- Fenêtres
Type d'application
- Applications natives
- Applications Web
Application
- Trouble lié à l'usage de substances (TUS)
- Trouble lié à l'usage d'opioïdes (TUO)
- Trouble du déficit de l'attention/hyperactivité (TDAH)
- Maladie d'Alzheimer
- Trouble dépressif majeur (TDM)
- Insomnie
- Épilepsie
- Trouble du mouvement
- Sclérose en plaques
- Migraine
- Trouble du spectre autistique
- Oncologie
- Inflammation
- Respiratoire
- Cardiovasculaire
- Gestion de la douleur
- Troubles métaboliques
- Autres
Patients
- Enfants
- Adultes
Analyse/perspectives régionales du marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique
Le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique est analysé et des informations sur la taille du marché et les tendances sont fournies par pays, mécanisme, catégorie, traitement, logiciel, services, accessibilité des applications, type d'application, application et patients comme référencé ci-dessus.
Les pays couverts dans le rapport sur le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique sont la Chine, le Japon, l'Inde, la Corée du Sud, Singapour, la Malaisie, l'Australie, la Thaïlande, l'Indonésie, les Philippines et le reste de l'Asie-Pacifique (APAC) dans l'Asie-Pacifique (APAC).
Le Japon domine le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique en termes de part de marché et de chiffre d'affaires et continuera à renforcer sa domination au cours de la période de prévision. Cela est dû à l'augmentation des dépenses de santé et à la prévalence croissante des maladies chroniques qui propulseront davantage le taux de croissance du marché dans cette région.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques d'Asie-Pacifique et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et des routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique
Le paysage concurrentiel du marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Asie-Pacifique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique.
Certains des principaux acteurs opérant sur le marché des thérapies numériques sur ordonnance (PDTx) en Asie-Pacifique sont :
- ResMed (États-Unis)
- SAMSUNGHEALTHCARE (Corée du Sud)
- Biofourmis (États-Unis)
- Novartis SA (Suisse)
- Medtronic (Irlande)
- Pear Therapeutics, Inc. (États-Unis)
- Voluntis (France)
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 MECHANISM OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INESIGHT
4.1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: LAWS AND REGULATIONS
4.2 PRINCIPLES FOR THE DEVELOPMENT OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) GUIDELINES
4.3 HIPAA COMPLIANCE FOR PRESCRIPTION DIGITAL THERAPEUTICS (PDTX)
5 EPIDERMOLOGY
6 PIPELINE ANALYSIS
6.1 LIST OF PIPELINE PRODUCTS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 PRESENCE OF PRODUCT PIPELINE
7.1.2 INCREASING PREVALANCE OF DISEASES
7.1.3 HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS
7.1.4 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES
7.1.5 PRESENCE OF REIMBURSEMENT
7.2 RESTRAINTS
7.2.1 UNAFFORDABILITY OF DIGITAL THERAPEUTICS
7.2.2 PRIVACY ISSUES IN PRESCRIPTION DIGITAL HEALTHCARE
7.2.3 RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDERS
7.3 OPPORTUNITIES
7.3.1 INCREASING FUNDING ACTIVITIES
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 EXPLORATION OF EMERGING MARKET
7.3.4 INCREASING HEALTHCARE EXPENDITURE
7.4 CHALLENGES
7.4.1 LACK OF SKILLED RESOURCES
7.4.2 EXISTENCE OF TRADITIONAL MEDICATIONS
7.4.3 LONG APPROVAL PROCEDURE
8 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM
9.1 OVERVIEW
9.2 INPUT MECHANISMS
9.2.1 PATIENT DATA COLLECTION
9.2.1.1 Cognition
9.2.1.2 Mood
9.2.1.3 Memory
9.2.1.4 Concentration
9.2.1.5 Familial Recognition
9.2.1.6 Others
9.2.2 DEXTERITY OR STEADINESS MEASUREMENT
9.2.2.1 Range of Motion Tests
9.2.2.2 Stretching
9.2.2.3 Others
9.2.3 AUDIO ANALYSIS
9.2.3.1 Shakiness
9.2.3.2 Voice Quality
9.2.3.3 Others
9.2.3.4 Screen
9.2.3.5 Accelerometer
9.2.3.6 Microphone
9.3 OUTPUT MECHANISMS
9.3.1 PATIENT COMMUNICATION
9.3.1.1 Professional Coaching
9.3.1.2 Peer-to-Peer Support
9.3.1.3 Others
9.3.2 ADHERENCE PROMPTS
9.3.2.1 Sleep
9.3.2.2 Diet
9.3.2.3 Inactivity
9.3.2.4 Others
9.3.3 CONTENT DELIVERY
9.3.3.1 Blogs
9.3.3.2 Tips
9.3.3.3 Videos
9.3.3.4 FAQs
9.3.3.5 Others
9.3.3.6 Chat
9.3.3.7 Notification
10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY
10.1 OVERVIEW
10.2 MEDICATION AUGMENTATION
10.3 MEDICATION REPLACEMENT
11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT
11.1 OVERVIEW
11.2 OUTPATIENT TREATMENT
11.2.1 COGNITIVE BEHAVIOR THERAPY (CBT)
11.2.2 CONTINGENCY MANAGEMENT
11.2.3 CRAVING OR TRIGGER ASSESSMENT
11.2.4 FLUENCY TRAINING
11.2.5 TRANSMUCOSAL BUPRENORPHINE
11.2.6 OTHERS
11.3 MONOTHERAPY
11.3.1 COGNITIVE RESTRUCTURING
11.3.2 INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBT)
11.3.3 OTHERS
12 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE
12.1 OVERVIEW
12.2 4.2 SOFTWARE FOR DIABETES
12.3 SOFTWARE FOR MENTAL HEALTH
12.4 SOFTWARE FOR RESPIRATORY CONDITIONS
12.5 SOFTWARE FOR OPIOID USE DISORDER
12.6 OTHERS
13 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES
13.1 OVERVIEW
13.2 BEHAVIORAL MICROSERVICES
13.2.1 PHYSICAL ACTIVITY
13.2.2 TELEMEDICINE
13.2.3 CONTROLLED BREATHING
13.2.4 MINDFULNESS TRAINING
13.2.5 RELAXATION TECHNIQUE
13.2.6 DIET OPTIMIZATION
13.2.7 OTHERS
13.3 MEDICAL MICROSERVICES
13.3.1 MEDICATION MANAGEMENT SYSTEM
13.3.2 PATIENT HEALTH QUESTIONNAIRE
13.3.3 HEALTH RECOVERED ENGINE
13.3.4 FAGERSTRÖM TEST
13.3.5 MORISKY MEDICATION ADHERENCE SCALE
13.3.6 FINANCIAL SAVING ENGINE
13.3.7 OTHERS
14 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY
14.1 OVERVIEW
14.2 ANDROID
14.2.1 SMARTPHONE
14.2.2 TABLET
14.3 OS
14.3.1 SMARTPHONE
14.3.2 TABLET
14.4 WINDOWS
14.4.1 SMARTPHONE
14.4.2 TABLET
15 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE
15.1 OVERVIEW
15.2 NATIVE APPS
15.3 WEB APPS
16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION
16.1 OVERVIEW
16.2 METABOLIC CONDITIONS
16.3 MAJOR DEPRESSIVE DIORDER (MDD)
16.4 RESPIRATORY
16.5 CARDIOVASCULAR
16.6 SUBSTANCE USE DISORDER (SUD)
16.7 OPIOID USE DISORDERS (OUD)
16.8 INSOMNIA
16.9 PAIN MANAGEMENT
16.1 ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
16.11 MOVEMENT DISORDER
16.12 INFLAMMATION
16.13 ONCOLOGY
16.14 MIGRAINE
16.15 ALZHEIMER’S DISEASE
16.16 EPILEPSY
16.17 MULTIPLE SCLEROSIS
16.18 AUSTISM SPECTRUM DISORDER
16.19 OTHERS
17 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS
17.1 OVERVIEW
17.2 ADULTS
17.3 CHILDREN
18 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY GEOGRAPHY
18.1 ASIA -PACIFIC
18.1.1 JAPAN
18.1.2 CHINA
18.1.3 AUSTRALIA
18.1.4 SOUTH KOREA
18.1.5 INDIA
18.1.6 SINGAPORE
18.1.7 THAILAND
18.1.8 MALAYSIA
18.1.9 INDONESIA
18.1.10 PHILIPPINES
18.1.11 VIETNAM
18.1.12 REST OF ASIA- PACIFIC
19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20 SWOT ANALYSIS
21 COMPANY PROFILE
21.1 OMADA HEALTH, INC.
21.1.1 COMPANY SNAPSHOT
21.1.2 PRODUCT PORTFOLIO
21.1.3 RECENT DEVELOPMENTS
21.2 RESMED
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMPANY SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENTS
21.3 SAMSUNG
21.3.1 COMPANY SNAPSHOT
21.3.2 REVENUE ANALYSIS
21.3.3 COMPANY SHARE ANALYSIS
21.3.4 PRODUCT PORTFOLIO
21.3.5 RECENT DEVELOPMENT
21.4 GAIA AG
21.4.1 COMPANY SNAPSHOT
21.4.2 COMPANY SHARE ANALYSIS
21.4.3 PRODUCT PORTFOLIO
21.4.4 RECENT DEVELOPMENTS
21.5 PEAR THERAPEUTICS, INC.
21.5.1 COMPANY SNAPSHOT
21.5.2 COMPANY SHARE ANALYSIS
21.5.3 PRODUCT PORTFOLIO
21.5.4 RECENT DEVELOPMENTS
21.6 WELLDOC’S BLUESTAR
21.6.1 COMPANY SNAPSHOT
21.6.2 PRODUCT PORTFOLIO
21.6.3 RECENT DEVELOPMENTS
21.7 SOLERA NETWORK
21.7.1 COMPANY SNAPSHOT
21.7.2 PRODUCT PORTFOLIO
21.7.3 RECENT DEVELOPMENTS
21.8 AKILI INTERACTIVE LABS, INC.
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENTS
21.9 BETTER THERAPEUTICS, LLC
21.9.1 COMPANY SNAPSHOT
21.9.2 PIPELINE PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENTS
21.1 BIGHEALTH
21.10.1 COMPANY SNAPSHOT
21.10.2 SOLUTION PORTFOLIO
21.10.3 RECENT DEVELOPMENT
21.11 BIOFOURMIS
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENTS
21.12 CLICK THERAPEUTICS, INC.
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENTS
21.13 HAPPIFY, INC.
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENTS
21.14 LIMBIX HEALTH, INC.
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENTS
21.15 NATURALCYCLES NORDIC AB
21.15.1 COMPANY SNAPSHOT
21.15.2 PRODUCT PORTFOLIO
21.15.3 RECENT DEVELOPMENTS
21.16 NUVOAIR AB
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 SENSYNE HEALTH PLC
21.17.1 COMPANY SNAPSHOT
21.17.2 REVENUE ANALYSIS
21.17.3 PRODUCT PORTFOLIO
21.17.4 RECENT DEVELOPMENTS
21.18 VOLUNTIS
21.18.1 COMPANY SNAPSHOT
21.18.2 REVENUE ANALYSIS
21.18.3 PRODUCT PORTFOLIO
21.18.4 RECENT DEVELOPMENTS
21.19 XEALTH
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS
TABLE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)
TABLE 4 ASIA-PACIFIC INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 5 ASIA-PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 6 ASIA-PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 7 ASIA-PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 8 ASIA-PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 9 ASIA-PACIFICINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 10 ASIA-PACIFIC OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 11 ASIA-PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 12 ASIA-PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 13 ASIA-PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 14 ASIA-PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 15 ASIA-PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)
TABLE 17 ASIA-PACIFIC MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 18 ASIA-PACIFIC MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)
TABLE 20 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 21 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 22 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)
TABLE 25 ASIA-PACIFIC SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 26 ASIA-PACIFIC SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 27 ASIA-PACIFIC SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)
TABLE 31 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 32 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 33 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 34 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)
TABLE 36 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)
TABLE 40 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 41 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)
TABLE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)
TABLE 43 ASIA-PACIFIC NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 44 ASIA-PACIFIC WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)
TABLE 46 ASIA-PACIFIC METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 47 ASIA-PACIFIC MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 48 ASIA-PACIFIC RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 49 ASIA-PACIFIC CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 50 ASIA-PACIFIC SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 51 ASIA-PACIFIC OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 52 ASIA-PACIFIC INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 53 ASIA-PACIFIC PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 54 ASIA-PACIFIC ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 55 ASIA-PACIFIC MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 56 ASIA-PACIFIC INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 57 ASIA-PACIFIC ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 58 ASIA-PACIFIC MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 59 ASIA-PACIFIC ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 60 ASIA-PACIFIC EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 61 ASIA-PACIFIC MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 62 ASIA-PACIFIC AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 63 ASIA-PACIFIC OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 64 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)
TABLE 65 ASIA-PACIFIC ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 66 ASIA-PACIFIC CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 67 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 68 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 69 ASIA- PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 70 ASIA- PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 71 ASIA- PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 72 ASIA- PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 73 ASIA- PACIFIC INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 74 ASIA- PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 75 ASIA- PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 76 ASIA- PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 77 ASIA- PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 78 ASIA- PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 79 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 80 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 81 ASIA- PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 82 ASIA- PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 83 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 84 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 85 ASIA- PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 86 ASIA- PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 87 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 88 ASIA- PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 89 ASIA- PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 90 ASIA- PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 91 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 92 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 93 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 94 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 95 JAPAN INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 96 JAPAN PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 97 JAPAN DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 98 JAPAN AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 99 JAPAN INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 100 JAPAN OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 101 JAPAN PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 102 JAPAN ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 103 JAPAN CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 104 JAPAN OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 105 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 106 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 107 JAPAN OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 108 JAPAN MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 109 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 110 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 111 JAPAN BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 112 JAPAN MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 113 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 114 JAPAN ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 115 JAPAN IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 116 JAPAN WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 117 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 118 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 119 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 120 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 121 CHINA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 122 CHINA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 123 CHINA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 124 CHINA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 125 CHINA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 126 CHINA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 127 CHINA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 128 CHINA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 129 CHINA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 130 CHINA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 131 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 132 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 133 CHINA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 134 CHINA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 135 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 136 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 137 CHINA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 138 CHINA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 139 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 140 CHINA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 141 CHINA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 142 CHINA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 143 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 144 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 145 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 146 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 147 AUSTRALIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 148 AUSTRALIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 149 AUSTRALIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 150 AUSTRALIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 151 AUSTRALIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 152 AUSTRALIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 153 AUSTRALIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 154 AUSTRALIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 155 USTRALIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 156 AUSTRALIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 157 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 158 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 159 AUSTRALIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 160 AUSTRALIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 161 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 162 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 163 AUSTRALIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 164 AUSTRALIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 165 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 166 AUSTRALIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 167 AUSTRALIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 168 AUSTRALIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 169 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 170
TABLE 171 USTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 172 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 173 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 174 SOUTH KOREA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 175 SOUTH KOREA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 176 SOUTH KOREA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 177 SOUTH KOREA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 178 SOUTH KOREA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 179 SOUTH KOREA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 180 SOUTH KOREA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 181 SOUTH KOREA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 182 SOUTH KOREA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 183 SOUTH KOREA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 184 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 185 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 186 SOUTH KOREA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 187 SOUTH KOREA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 188 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 189 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 190 SOUTH KOREA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 191 SOUTH KOREA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 192 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 193 SOUTH KOREA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 194 SOUTH KOREA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 195 SOUTH KOREA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 196 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 197 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 198 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 199 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 200 INDIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 201 INDIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 202 INDIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 203 INDIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 204 INDIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 205 INDIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 206 INDIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 207 INDIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 208 INDIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 209 INDIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 210 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 211 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 212 INDIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 213 INDIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 214 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 215 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 216 INDIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 217 INDIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 218 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 219 INDIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 220 INDIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 221 INDIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 222 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 223 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 224 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 225 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 226 SINGAPORE INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 227 SINGAPORE PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 228 SINGAPORE DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 229 SINGAPORE AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 230 SINGAPORE INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 231 INGAPORE OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 232 SINGAPORE PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 233 SINGAPORE ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 234 SINGAPORE CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 235 SINGAPORE OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 236 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 237 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 238 SINGAPORE OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 239 SINGAPORE MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 240 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 241 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 242 SINGAPORE BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 243 SINGAPORE MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 244 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 245 SINGAPORE ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 246 SINGAPORE IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 247 SINGAPORE WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 248 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 249 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 250 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 251 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 252 THAILAND INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 253 THAILAND PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 254 THAILAND DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 255 THAILAND AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 256 THAILAND INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 257 THAILAND OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 258 THAILAND PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 259 THAILAND ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 260 THAILAND CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 261 THAILAND OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 262 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 263 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 264 THAILAND OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 265 THAILAND MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 266 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 267 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 268 THAILAND BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 269 THAILAND MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 270 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 271 THAILAND ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 272 THAILAND IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 273 THAILAND WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 274 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 275 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 276 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 277 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 278 MALAYSIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 279 MALAYSIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 280 MALAYSIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 281 MALAYSIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 282 MALAYSIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 283 MALAYSIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 284 MALAYSIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 285 MALAYSIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 286 MALAYSIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 287 MALAYSIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 288 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 289 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 290 MALAYSIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 291 MALAYSIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 292 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 293 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 294 MALAYSIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 295 MALAYSIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 296 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 297 MALAYSIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 298 MALAYSIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 299 MALAYSIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 300 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 301 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 302 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 303 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 304 INDONESIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 305 INDONESIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 306 INDONESIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 307 INDONESIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 308 INDONESIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 309 INDONESIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 310 INDONESIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 311 INDONESIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 312 INDONESIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 313 INDONESIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 314 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 315 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 316 INDONESIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 317 INDONESIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 318 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 319 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 320 INDONESIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 321 INDONESIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 322 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 323 INDONESIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 324 INDONESIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 325 INDONESIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 326 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 327 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 328 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 329 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 330 PHILIPPINES INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 331 PHILIPPINES PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 332 PHILIPPINES DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 333 PHILIPPINES AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 334 PHILIPPINES INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 335 HILIPPINES OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 336 PHILIPPINES PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 337 PHILIPPINES ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 338 PHILIPPINES CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 339 PHILIPPINES OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 340 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 341 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 342 PHILIPPINES OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 343 PHILIPPINES MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 344 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 345 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 346 PHILIPPINES BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 347 PHILIPPINES MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 348 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 349 PHILIPPINES ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 350 PHILIPPINES IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 351 PHILIPPINES WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 352 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 353 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 354 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 355 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 356 VIETNAM INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 357 VIETNAM PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 358 VIETNAM DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 359 VIETNAM AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 360 VIETNAM INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 361 VIETNAM OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 362 VIETNAM PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 363 VIETNAM ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 364 VIETNAM CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 365 VIETNAM OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
TABLE 366 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)
TABLE 367 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 368 VIETNAM OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 369 VIETNAM MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 370 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)
TABLE 371 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 372 VIETNAM BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 373 VIETNAM MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)
TABLE 374 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 375 VIETNAM ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 376 VIETNAM IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 377 VIETNAM WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)
TABLE 378 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)
TABLE 379 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)
TABLE 380 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)
TABLE 381 REST OF ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION
FIGURE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION
FIGURE 12 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES AND HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS IS DRIVING THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
FIGURE 13 INPUT MECHANISMS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN 2020 & 2027
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET
FIGURE 15 DEATH CAUSE IN EUROPEAN UNION IN 2016
FIGURE 16 OCCURRENCE OF MIGRAINE AS PER THE AUSTRALIAN AND NEW ZEALAND ASSOCIATION OF NEUROLOGISTS ANNUAL SCIENTIFIC MEETING 2017
FIGURE 17 PROJECTED NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (IN MILLIONS)
FIGURE 18 PERCENTAGE OF INTERNET USERS IN 2016 AND 2019
FIGURE 19 HEALTHCARE EXPENDITURE IN 2016 AND 2019
FIGURE 20 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019
FIGURE 21 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019-2027 (USD MILLION)
FIGURE 22 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, CAGR (2020-2027)
FIGURE 23 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019
FIGURE 25 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019-2027 (USD MILLION)
FIGURE 26 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, CAGR (2020-2027)
FIGURE 27 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019
FIGURE 29 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)
FIGURE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, CAGR (2020-2027)
FIGURE 31 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019
FIGURE 33 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019-2027 (USD MILLION)
FIGURE 34 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, CAGR (2020-2027)
FIGURE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019
FIGURE 37 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019-2027 (USD MILLION)
FIGURE 38 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, CAGR (2020-2027)
FIGURE 39 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019
FIGURE 41 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019-2027 (USD MILLION)
FIGURE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, CAGR (2020-2027)
FIGURE 43 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019
FIGURE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019-2027 (USD MILLION)
FIGURE 46 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, CAGR (2020-2027)
FIGURE 47 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, LIFELINE CURVE
FIGURE 48 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019
FIGURE 49 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)
FIGURE 50 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, CAGR (2020-2027)
FIGURE 51 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019
FIGURE 53 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019-2027 (USD MILLION)
FIGURE 54 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, CAGR (2020-2027)
FIGURE 55 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, LIFELINE CURVE
FIGURE 56 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SNAPSHOT (2019)
FIGURE 57 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019)
FIGURE 58 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2020 & 2027)
FIGURE 59 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019 & 2027)
FIGURE 60 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM (2020-2027)
FIGURE 61 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY SHARE 2019 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
